Dosage for Tresiba (insulin degludec) depends on the type of diabetes (type 1 or type 2) it is prescribed for and other factors. Your doctor may adjust your dosage over the course of your treatment.

NovoLog (insulin aspart) is a prescription medication used to manage blood sugar levels in people with type 1 or type 2 diabetes. NovoLog dosage varies based on individual factors such as the type of ...

NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...

Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...

Weekly insulin dose aces phase 3 trials for easier diabetes management By Michael Irving October 30, 2023 A once-a-week insulin shot has shown promise in a phase three clinical trial Depositphotos ...

Eli Lilly and Co (NYSE:LLY) released Thursday topline results from two phase 3 trials. The drugmaker evaluated once-weekly insulin efsitora alfa (efsitora) in type 2 diabetes patients using insulin ...

Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...

Parents of school children with diabetes can once again share input with school nurses on changes in the daily insulin dose at school — the product of a settlement between state education and ...

Dr. Yuanjie Mao has led a study published in the Journal of the American Medical Association (JAMA) Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of ...

Tandem Diabetes Care says the Food and Drug Administration (FDA) has cleared its smartphone app to program and cancel insulin doses from the t:slim X2 insulin pump. The company claims it's the first ...

Bioengineers at UCLA and several other universities have developed a smart insulin-delivery patch that they say could one day monitor and manage glucose levels in people with diabetes and deliver ...